Brokerages predict that Viewray Inc (NASDAQ:VRAY) will report earnings per share (EPS) of ($0.29) for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Viewray’s earnings, with estimates ranging from ($0.34) to ($0.25). Viewray reported earnings of ($0.25) per share in the same quarter last year, which indicates a negative year-over-year growth rate of 16%. The business is scheduled to issue its next quarterly earnings report on Thursday, November 14th.

On average, analysts expect that Viewray will report full year earnings of ($1.21) per share for the current year, with EPS estimates ranging from ($1.33) to ($1.10). For the next year, analysts forecast that the firm will report earnings of ($0.88) per share, with EPS estimates ranging from ($1.11) to ($0.65). Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that that provide coverage for Viewray.

Viewray (NASDAQ:VRAY) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.32) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.23) by ($0.09). Viewray had a negative net margin of 128.13% and a negative return on equity of 62.98%. The business had revenue of $30.17 million during the quarter, compared to analysts’ expectations of $25.92 million. During the same period in the prior year, the firm posted ($0.30) EPS. Viewray’s revenue for the quarter was up 83.5% compared to the same quarter last year.

VRAY has been the topic of a number of analyst reports. Mizuho reaffirmed a “buy” rating and issued a $9.00 price objective on shares of Viewray in a report on Sunday. Piper Jaffray Companies assumed coverage on Viewray in a report on Tuesday, June 18th. They issued an “overweight” rating and a $15.00 price target for the company. TheStreet downgraded Viewray from a “c-” rating to a “d” rating in a report on Friday, May 3rd. Morgan Stanley set a $5.00 price target on Viewray and gave the company a “hold” rating in a report on Monday. Finally, Zacks Investment Research downgraded Viewray from a “hold” rating to a “sell” rating in a report on Friday, August 9th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $11.75.

In other news, CEO Scott William Drake acquired 131,260 shares of the company’s stock in a transaction dated Tuesday, August 13th. The stock was acquired at an average cost of $3.81 per share, for a total transaction of $500,100.60. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Shahriar Matin acquired 60,000 shares of the company’s stock in a transaction dated Wednesday, August 14th. The shares were purchased at an average price of $4.02 per share, with a total value of $241,200.00. The disclosure for this purchase can be found here. Corporate insiders own 15.48% of the company’s stock.

Large investors have recently bought and sold shares of the business. Great West Life Assurance Co. Can purchased a new position in Viewray in the 4th quarter valued at about $45,000. Citigroup Inc. boosted its holdings in Viewray by 146.5% during the fourth quarter. Citigroup Inc. now owns 8,121 shares of the company’s stock worth $49,000 after purchasing an additional 4,826 shares during the last quarter. Bank of Montreal Can boosted its holdings in Viewray by 4,390.1% during the second quarter. Bank of Montreal Can now owns 5,882 shares of the company’s stock worth $52,000 after purchasing an additional 5,751 shares during the last quarter. Advisory Services Network LLC acquired a new position in Viewray during the fourth quarter worth $56,000. Finally, Cutler Group LP acquired a new stake in shares of Viewray in the 1st quarter valued at approximately $76,000.

VRAY traded down $0.08 during trading on Thursday, reaching $3.93. The company’s stock had a trading volume of 2,237,859 shares, compared to its average volume of 1,411,491. Viewray has a 52-week low of $2.76 and a 52-week high of $10.73. The firm has a fifty day moving average of $8.17. The company has a market capitalization of $387.03 million, a P/E ratio of -4.01 and a beta of 0.79. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.28 and a quick ratio of 3.21.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Featured Story: Why are percentage gainers important?

Get a free copy of the Zacks research report on Viewray (VRAY)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with's FREE daily email newsletter.